Loon Lens outperforms Catchii for title and abstract screening in Parkinson Disease research
Agentic AI Tools Show Promise for Screening Parkinson Disease Research
This systematic review evaluates the performance of agentic AI tools, specifically Loon Lens and Catchii, for screening titles and abstracts…
New research shows that specific AI tools can help researchers identify relevant studies on Parkinson disease more accurately than other aut…
Intensive blood pressure lowering reduces severe cerebral oedema risk in acute ischemic stroke patients
Lowering Blood Pressure Quickly After Stroke May Reduce Brain Swelling
This secondary analysis of a randomized controlled trial involved 1,477 patients with thrombolysed acute ischemic stroke. The study found th…
A large study found that rapidly lowering blood pressure within the first hour after a stroke may reduce the risk of severe brain swelling, …
Thrombolysis plus endovascular therapy for basilar artery occlusion: a trial protocol
New trial plans to test stroke treatments for basilar artery
This randomized controlled trial protocol will compare intravenous thrombolysis plus endovascular treatment versus direct endovascular treat…
A large multi-center trial in China aims to see if adding clot-busting drugs improves recovery for patients with a specific type of stroke.
Verbal fluency is significantly impaired in multiple sclerosis and neuromyelitis optica spectrum disorders
Speech Fluency Linked to Cognitive Function in MS and NMOSD
This meta-analysis of 69 studies evaluates verbal fluency in patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorde…
People with multiple sclerosis and NMOSD often show lower verbal fluency scores compared to healthy individuals, highlighting a link to cogn…
FDA Approves Xeomin (incobotulinumtoxinA) for Chronic Sialorrhea in Patients 2 Years and Older
FDA approves Xeomin to treat chronic drooling in adults and children
The FDA approved Xeomin (incobotulinumtoxinA) for chronic sialorrhea in patients aged 2 years and older. Dosing is based on body weight in p…
The FDA approved Xeomin (incobotulinumtoxinA) for chronic sialorrhea (drooling) in patients aged 2 and older. It is the first botulinum toxi…
Evaluating High Frequency Repetitive Transcranial Magnetic Stimulation for Post Stroke Cognitive Impairment
Magnetic brain stimulation may improve memory after a stroke
Meta-analysis results indicate that HF-rTMS significantly improves various memory functions in patients suffering from post-stroke cognitive…
A large review of data suggests that high-frequency magnetic stimulation could help improve memory for people living with post-stroke cognit…
Efficacy of Levodopa Based Therapy for Motor and Cognitive Recovery After Stroke
Levodopa does not improve movement after a stroke
A meta-analysis involving 1,257 patients found that adding levodopa to standard stroke rehabilitation yields no significant improvement in m…
A large review of stroke recovery shows that adding levodopa to rehabilitation does not improve physical movement, mood, or thinking.
EEG microstate duration and occurrence rates differ significantly between Alzheimer's patients and healthy controls
Brain wave patterns show differences in Alzheimer's and memory loss
This meta-analysis of 16 studies evaluated EEG microstate parameters in patients with Alzheimer's disease (AD) and mild cognitive impairment…
New analysis shows specific brain wave patterns change as memory fades, offering a new way to look at how the brain handles information.
Resistance training improves quality of life in Parkinson's disease, meta-analysis finds
Resistance training improves quality of life for Parkinson's disease
This meta-analysis found that resistance training improves quality of life in Parkinson's disease compared to control (SMD -0.81, CI -1.45 t…
New data shows that resistance training helps people with Parkinson's disease enjoy a better quality of life compared to no exercise.
Plasma p-tau217 and Aβ42/40 biomarkers show high AUC for discriminating amyloid PET positivity
Blood Tests May Help Identify Early Signs of Alzheimer's
This meta-analysis of 9 studies involving 2566 cognitively unimpaired Asian individuals found that plasma p-tau217 (AUC 0.88) and Aβ42/40 (A…
New research shows that specific blood markers can help identify early signs of amyloid buildup in the brain for people without memory loss.
194 miRNAs exhibit widespread changes in Alzheimer's disease and influence key biological pathways
194 microRNAs show widespread changes in Alzheimer's disease
This meta-analysis of 22 studies identifies 194 miRNAs with widespread changes in Alzheimer's disease. The analysis highlights the involveme…
A meta-analysis of 22 studies found 194 microRNAs with widespread changes in Alzheimer's disease, including novel ones. These miRNAs affect …
Dual antiplatelet therapy reduces stroke recurrence in patients with acute mild ischaemic stroke
Dual Antiplatelet Therapy Reduces Stroke Risk in Mild Cases
This meta-analysis evaluated dual antiplatelet therapy compared to monotherapy in patients with acute mild ischaemic stroke or TIA. The anal…
New data shows dual antiplatelet therapy can lower stroke recurrence for patients with mild ischemic strokes or TIA, despite higher bleeding…